Cargando…

Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: An optical coherence tomography study

BACKGROUND: High lipoprotein (a) [Lp(a)] levels are an independent factor for worse prognosis in patients with coronary artery disease (CAD). However, the association between serum Lp(a) level and coronary plaque vulnerability remains to be determined. METHODS: A total of 255 consecutive patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muramatsu, Yusuke, Minami, Yoshiyasu, Kato, Ayami, Katsura, Aritomo, Sato, Toshimitsu, Kakizaki, Ryota, Nemoto, Teruyoshi, Hashimoto, Takuya, Fujiyoshi, Kazuhiro, Meguro, Kentaro, Shimohama, Takao, Ako, Junya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582072/ https://www.ncbi.nlm.nih.gov/pubmed/31245530 http://dx.doi.org/10.1016/j.ijcha.2019.100382

Ejemplares similares

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
por: Kakizaki, Ryota, et al.
Publicado: (2020)

Lipoprotein (a) levels and vulnerable characteristics in nonculprit plaque in patients with acute coronary syndrome()
por: Kato, Ayami, et al.
Publicado: (2022)

Lower Level of Low Density Lipoprotein Cholesterol is Associated with a Higher Increase in the Fractional Flow Reserve in Patients with Fixed-dose Rosuvastatin
por: Hashikata, Takehiro, et al.
Publicado: (2018)

Familial hypercholesterolemia and vulnerability of coronary plaque in patients with coronary artery disease
por: Katamine, Masahiro, et al.
Publicado: (2021)

Myocardial ischemia induced by major aortopulmonary collateral arteries treated with transcatheter coil embolization
por: Kakizaki, Ryota, et al.
Publicado: (2017)

Vascular response and intrastent thrombus in the early phase after drug‐eluting versus bare‐metal stent implantation in patients with ST‐segment elevation myocardial infarction: An observational, single‐center study
por: Sato, Nobuhiro, et al.
Publicado: (2018)

Lower limb ischemia due to popliteal artery compression by Baker cyst
por: Fujiyoshi, Kazuhiro, et al.
Publicado: (2018)

Tako-tsubo-like left ventricular dysfunction in a patient with COVID-19 demonstrated by non-invasive multi-modality imaging
por: Fujiyoshi, Kazuhiro, et al.
Publicado: (2020)

Effect of cardiac rehabilitation on cognitive function in elderly patients with cardiovascular diseases
por: Fujiyoshi, Kazuhiro, et al.
Publicado: (2020)

T-wave flattening and positive U-wave in the acute phase of isolated septal infarction
por: Kakizaki, Ryota, et al.
Publicado: (2023)

Right atrial infarction causing recurrent cardiac rupture and cardiac tamponade
por: Kakizaki, Ryota, et al.
Publicado: (2023)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
por: Kim, Jeong Hun, et al.
Publicado: (2012)

Very late stent thrombosis lacking findings of the typical causes on optical coherence tomography in a patient with SARS-CoV-2
por: Shinkai, Wataru, et al.
Publicado: (2022)

Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis
por: Namba, Sayaka, et al.
Publicado: (2015)

Neuroimaging of the Vulnerable Plaque
por: Lovblad, Karl-Olof, et al.
Publicado: (2015)

Lipoprotein (a) is related to In-Stent neoatherosclerosis incidence rate and plaque vulnerability: Optical Coherence Tomography Study
por: Yuan, Xiaohang, et al.
Publicado: (2022)

Data on the lipoprotein (a), coronary atherosclerotic burden and vulnerable plaque phenotype in angiographic obstructive coronary artery disease
por: Niccoli, Giampaolo, et al.
Publicado: (2016)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Role of lipoprotein(a) in plaque progression
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A(2) in human vulnerable atherosclerotic plaque
por: Li, Jingjin, et al.
Publicado: (2021)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Intraplaque haemorrhages as the trigger of plaque vulnerability
por: Michel, Jean-Baptiste, et al.
Publicado: (2011)

Intracoronary Imaging in the Detection of Vulnerable Plaques
por: Batty, Jonathan A., et al.
Publicado: (2016)

Noninvasive diagnosis of vulnerable coronary plaque
por: Pozo, Eduardo, et al.
Publicado: (2016)

Gender Differences of Plaque Characteristics in Elderly Patients with Stable Angina Pectoris: An Intravascular Ultrasonic Radiofrequency Data Analysis
por: Nakamura, Tomohiro, et al.
Publicado: (2010)

Clinical and Laboratory Predictors for Plaque Erosion in Patients With Acute Coronary Syndromes
por: Yamamoto, Erika, et al.
Publicado: (2019)

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
por: Kaiser, Yannick, et al.
Publicado: (2022)

Correlation Between Calcification Characteristics of Carotid Atherosclerotic Plaque and Plaque Vulnerability
por: Xu, Xiangli, et al.
Publicado: (2021)

Relationship of Neutrophil-to-Lymphocyte Ratio with Carotid Plaque Vulnerability and Occurrence of Vulnerable Carotid Plaque in Patients with Acute Ischemic Stroke
por: Li, Xin, et al.
Publicado: (2021)

Association Between Plasma Lipoprotein-Associated Phospholipase A2 and Plaque Vulnerability in TIA Patients With Unilateral Middle Cerebral Artery Stenosis
por: Qin, Yiren, et al.
Publicado: (2020)

Automated diagnosis of optical coherence tomography imaging on plaque vulnerability and its relation to clinical outcomes in coronary artery disease
por: Niioka, Hirohiko, et al.
Publicado: (2022)

Identification of vulnerable carotid plaque with histologically validated CT-derived plaque maps
por: Obaid, Daniel Rhys, et al.
Publicado: (2023)

Ultrasound Tissue Characterization of Vulnerable Atherosclerotic Plaque
por: Picano, Eugenio, et al.
Publicado: (2015)

Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques
por: Lee, Soo Jin, et al.
Publicado: (2015)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

Vulnerable Plaque, Characteristics, Detection, and Potential Therapies
por: Hafiane, Anouar
Publicado: (2019)

Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
por: Mangge, Harald, et al.
Publicado: (2019)

Calcification in Atherosclerotic Plaque Vulnerability: Friend or Foe?
por: Shi, Xuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p8r0n0hf8cb99t9msnclcrfer4